PharmaVOICE - 
Nov./Dec. 2007
Purchase Issue

In Every Issue
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Verispan and [...]
By
Raise Your Voice — Letters
Flawless Execution The most successful brand and product managers are [...]
By
UpFront
Scientific Splashdown Pharma Provides Robust Level of Information According to [...]
By
On the Calendar
November 15 The Pharmaceutical Business From Drug Discovery Through Product [...]
By
Talent Pool
Executive Appointments and Promotions Pharma POOL Aaron D. Berg Mark [...]
By
What’s New
What’s New New Healthcare-related Products, Services, and Companies CommonHealth Seeks [...]
By

On The Cover

Letter from the Editor
By Taren Grom, Editor Contemplating the year ahead As we move into 2008, it appears that there are many more questions than answers for the industry. Certainly, the upcoming presidential election is on everyone’s minds. The healthcare platforms presented by the front runners are being dissected and analyzed. No matter what your political affiliation is [...]
By

Taren Grom, Editor

Features

Basic Research
New tools and technologies will provide new ways of looking at diseases, which could lead to a pipeline of new products. Start with the end in mind: patients. Leaders in drug discovery and research say this should guide how the biopharmaceutical industry approaches new medicines now and in the future. The challenge is to align [...]
By

Denise Myshko

Then & Now
Thought leaders review their 2006 predictions in 2007. PharmaVOICE asked experts who participated in last year’s issue to review their predictions for 2007 and evaluate whether their forecasts came to fruition and why or why not. (Editor’s Note: Predictions are presented in alphabetical order by contributor’s last name.) Separating Pharma and Biotech Joseph Brindisi VP, [...]
By
Stem Cells
By Kim Ribbink Experts discuss the milestones that have been achieved and the implications for stem-cell therapeutics. The Stem of Hope New findings and understandings about the way stem cells operate and their potential in therapeutic development have led to real hope that there could soon be treatments for life-threatening diseases. Experts in the field [...]
By

Kim Ribbink

Crystal Ball
Industry experts identify the top trends they expect to shape the industry. We asked our industry experts to identify the top trends that they expect to shape the industry in the coming year and beyond. Some of their responses may surprise you; others may already be on your radar. You may agree with some and [...]
By
An Industry Overview
BY ROBIN ROBINSON The strategic plans for 2008 in the industry appear to be business as usual, which may not bode well for its future, according to PricewaterhouseCoopers’ (PWC) latest report. According to Pharma 2020: The Vision report, to make the most of future growth opportunities, the industry must fundamentally change the way it operates. [...]
By

Robin Robinson

Medicare Part D
Industry experts evaluate the impact of Medicare Part D and project what further market- shaping events are to come. For consumers, the implementation of Medicare Part D has mostly been positive — reduced out-of-pocket costs and improved access to medicines. According to a study by The Amundsen Group Inc. based on prescription data provided by [...]
By

Denise Myshko

New Worlds of Opportunities Clinical Development
By Denise Myshko Technology will be the change agent for overhauling development processes to reduce costs and increase efficiencies. The development process needs to undergo a major overhaul to reduce costs and increase efficiencies to bring new medicines to market in a more timely manner. The change agent? Technology, of course. Analysts, experts, and CEOs [...]
By

Denise Myshko

The Corner Office
A review of commentary from more than two dozen of the CEOs and Presidents of leading life-sciences companies reveals some top trends. A review of the annual reports, public statements, and exclusive commentary from almost two dozen of the industry’s pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs, presidents, and executive management [...]
By
Marketing
Marketers are changing their messages in light of a DTC pullback and a rising tide of nontraditional outlets and tools. Industry experts are divided as to how rapidly pharmaceutical marketers will embrace new and emerging technologies to capitalize on the number of opportunities new media afford. Some in the industry, such as David Harrell, president [...]
By

Taren Grom, Editor

Salesforces
By Taren Grom, Editor A new sales model will emerge that uses sophisticated selling techniques, technologies, and education. The Salesforce of the Future In the future, the salesforce army of today will be but a distant memory as a new sales model emerges that uses sophisticated selling techniques, technologies, and education to support the rep’s [...]
By

Taren Grom, Editor

The FDA
A new law is expected to have an immediate and significant impact on the Food and Drug Administration. By Denise Myshko Tightening the Regulatory Reins The new law passed in September 2007 is expected to have an immediate and significant impact on the Food and Drug Administration’s authority over manufacturing and marketing. Right off the [...]
By

Denise Myshko

Doctors’ Choice Awards
The doctors’ choice awards, an annual study conducted by the Association of Medical Media (formerly the Association of Medical Publications), is the only program that is voted on by the industry’s customers — the physicians. Winners are selected according to their scores in an independent Internet survey measuring physicians’ attitudes toward product advertising in medical [...]
By
FEEDBACK